SPY319.34+8.04 2.58%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Regenxbio Q1 EPS $(1.080) Misses $(0.870) Estimate, Sales $17.644M Miss $18.450M Estimate

Regenxbio (NASDAQ:RGNX) reported quarterly losses of $(1.080) per share which missed the analyst consensus estimate of $(0.870) by 24.14 percent. This is a 21.35 percent decrease over losses of $(0.890) per share from

Benzinga · 05/07/2020 20:28

Regenxbio (NASDAQ:RGNX) reported quarterly losses of $(1.080) per share which missed the analyst consensus estimate of $(0.870) by 24.14 percent. This is a 21.35 percent decrease over losses of $(0.890) per share from the same period last year. The company reported quarterly sales of $17.644 million which missed the analyst consensus estimate of $18.450 million by 4.37 percent. This is a 1.90K percent increase over sales of $884.000 thousand the same period last year.